Feb 13 Special Seminar

Strominger Lecture

Holiday Party 2019

Symposium to present the ARTiMIS Alliance

ARTiMIS is an alliance between HMS and Moderna Therapeutics to provide access to a novel platform for mRNA delivery to immune cells.
ARTiMIS will also offer funding for pilot projects and the opportunity to collaborate with Moderna scientists.

Thursday, September 26, 2019
12:30 PM – 4:00 PM (reception to follow)
Harvard Medical School
New Research Building, Room 1031
77 Avenue Louis Pasteur, Boston  

Welcome Remarks

 Arlene Sharpe: Chair, Department of Immunology
 David Golan: Dean for Research Operations & Global Programs

Introduction to ARTiMIS

 Uli von Andrian: ARTiMIS Program Director

Introduction to Moderna

 Stephen Hoge: President, Moderna

Overview of Platform

 Melissa Moore: Chief Scientific Officer, Research Platform, Moderna

Examples of Platform Use in Mammalian Immune Cells

 Gilles Besin: Senior Director of Immunology, Moderna

Introduction to Additional Moderna Research Areas

 Josh Frederick: Head of Oncology Research
 Eric Huang: Chief Scientific Officer, New Venture Labs
 Andrea Carfio: Head, Infectious Disease Research

For more information about Moderna Therapeutics, please visit their website.

Immunology Retreat